mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.3 |